Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $70.38 USD
Change Today 0.00 / 0.00%
Volume 0.0
CRL On Other Exchanges
New York
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Davide A. Molho D.V.M.

Corporate Executive Vice President and President of Global Research Models & Services, Safety Assessment & Biologics,Charles River Laboratories International, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Davide Molho, D.V.M. has been the Corporate Executive Vice President at Charles River Laboratories International, Inc. since December 9, 2013 and has been President of Global Research Models & Services, Safety Assessment & Biologics since December 2013. Dr. Molho served as President of Global Research Models & Services & DSA Operations at Charles River Laboratories International, Inc. Dr. Molho served as President of Global Research Models & Services & Preclinical ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: 978-988-5665

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education
Universita' degli Studi di Milano
Master's Degree
Universita' degli Studi di Milano

Other Affiliations*

Annual Compensation*

Total Annual Compensation$524,883

Stock Options*

Restricted Stock Awards$1,520,977
All Other Compensation$110,846
Exercised Options60,162
Exercised Options Value$1,293,706
Exercisable Options16,577
Exercisable Options Value$441,986
Unexercisable Options58,065
Unexercisable Options Value$1,045,833
Total Value of Options$2,781,524
Total Number of Options134,804

Total Compensation*

Total Annual Cash Compensation$1,174,922
Total Short Term Compensation$524,883
Other Long Term Compensation$1,631,823
Total Calculated Compensation$3,036,820
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $70.38 USD 0.00


Jacqueline M. Lemke Chief Executive Officer, President and Director
Bioanalytical Systems Inc.
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
Colin Shannon Chairman, Chief Executive Officer and President
PRA Health Sciences, Inc.
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
152.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at